Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
2.580
-0.360 (-12.24%)
Oct 17, 2025, 4:00 PM EDT - Market closed
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $3.85 million as of October 17, 2025. Its market cap has increased by 89.55% in one year.
Market Cap
3.85M
Enterprise Value
-411.31K
1-Year Change
89.55%
Ranking
Category
Stock Price
$2.58
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $3.85M, a decrease of -94.29%. That is a compound annual growth rate of -51.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 3.85M | 43.27% |
| Dec 31, 2024 | 2.69M | 78.03% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
| Nov 10, 2021 | 67.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.59B |
| Johnson & Johnson | 462.69B |
| AbbVie | 400.78B |
| UnitedHealth Group | 323.03B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 222.13B |